Biotechnology
RSS Feed

Mymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines
11/14/2018 -- 5:35 AM -- Mymetics Corporation

ABMC Reports Third Quarter 2018 Results
11/13/2018 -- 2:30 PM -- American Bio Medica Corporation

Zivo Claims Gras Status for its Proprietary Algal Biomass, Allowing Immediate Marketing of its Premiere Product as a Human Food Ingredient
11/12/2018 -- 9:00 PM -- Zivo Bioscience, Inc.

Pressure BioSciences Achieves Major Milestone in the Development of its Ultra Shear Technology Program
11/9/2018 -- 11:50 AM -- Pressure BioSciences, Inc.

Dyadic International Reports Third Quarter 2018 Financial Results
11/7/2018 -- 4:30 PM -- Dyadic International, Inc.

Qrons Enters into Placenta Sourcing Agreement under the Declaration of Helsinki
11/7/2018 -- 11:45 AM -- Qrons Inc.

Bradford A. Young, Ph.D., MBA Joins Pressure BioSciences as Chief Commercial Officer
11/7/2018 -- 9:45 AM -- Pressure BioSciences, Inc.

Molecular Partners to Present New Data on Immuno-Oncology Pipeline at Upcoming Scientific Conferences
11/6/2018 -- 12:36 AM -- Molecular Partners AG

VTT and Dyadic International to Present Data on C1 Protein Platform at AAPS PharmSci 360 and PEGS Europe
11/5/2018 -- 9:45 AM -- Dyadic International, Inc.

Dyadic Announces the Filing of Initial Form 10 Registration Statement with the SEC
11/5/2018 -- 8:30 AM -- Dyadic International, Inc.

Neocis Names Fred Moll, M.D. to Board of Directors
11/1/2018 -- 1:10 PM -- Neocis, Inc.

Positive Phase 3 Efficacy Data for Abicipar, Ongoing Clinical Trials for MP0250 In Oncology and Further Advancement of I/O Pipeline
11/1/2018 -- 2:00 AM -- Molecular Partners AG

INmune Bio to Present at National Investment Banking Association Conference
10/30/2018 -- 8:30 AM -- INmune Bio, Inc

Theranexus Announces Inclusion of Last Patient in Phase II Trial of Drug Candidate THN102 on Narcolepsy Patients
10/29/2018 -- 10:25 AM -- Theranexus

Abicipar Phase 3 Data Presented at AAO Conference in Chicago: Potential to be the First Fixed 12-week Anti-VEGF Therapeutic
10/29/2018 -- 2:00 AM -- Molecular Partners AG

Viridium Reports Fiscal 2018 Third Quarter Results
10/24/2018 -- 8:10 PM -- Viridium Pacific Group Ltd.

Dyadic to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018
10/24/2018 -- 4:30 PM -- Dyadic International, Inc.

Vitro BioPharma Engages Senior Director of Sales and Marketing
10/23/2018 -- 1:40 PM -- Vitro Diagnostics, Inc.

Prolung Shareholder Group Led by Founder and Former CEO Steve Eror Delivers More than the Requisite Number of White Card Consents to Enlarge and Enhance the Board
10/22/2018 -- 5:50 PM -- Enlarge and Enhance My Board